A Study Comparing Skin Fluorescence to Coronary Artery Calcification

Completed

Conditions studied: Diabetes, Coronary Artery Calcification

In brief

This study examines the relationship between the SCOUT DM device and coronary artery calcification as determined by rapid computed tomography in patients at risk for coronary heart disease.

Key facts

Study ID

NCT00895427

Run by

VeraLight, Inc.

People needed

240

Starts

2009-02-01

Expected to finish

2011-09-01

Last updated by the study team

2011-10-12

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males ≥ 45 years or females ≥ 50 years old that have had a coronary artery calcification score determined by rapid computed tomography at the clinical site within the last six months.

You may not qualify if…

• Receiving investigational treatments
• Psychosocial issues that interfere with an ability to follow study procedures
• Known to be pregnant
• Receiving dialysis or having known renal compromise
• Scars, tattoos, rashes or other disruption/discoloration on the left volar forearm.
• Recent or current oral steroid therapy or topical steroids applied to the left forearm
• Current chemotherapy, or chemotherapy within the past 12 months
• Receiving medications that fluoresce*
• Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity)

Where it is running

• New Mexico Heart Institute — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.